Knebel Fabian, Schimke Ingolf, Pliet Kathleen, Schattke Sebastian, Martin Salim, Borges Adrian C, Baumann Gert
Medical Clinic for Cardiology, Angiology, and Pneumology, Charité Campus Mitte--University Medicine, Berlin, Germany.
J Card Fail. 2005 Jun;11(5 Suppl):S38-41. doi: 10.1016/j.cardfail.2005.04.012.
N-terminal brain natriuretic peptide (NT-proBNP) level is elevated in patients with acute and chronic heart failure. This study addresses whether NT-proBNP correlates with invasively measured hemodynamic parameters and whether a decrease of NT-proBNP over time correlates with invasively monitored hemodynamic improvement.
Twenty consecutive patients with acute exacerbation of chronic heart failure (New York Heart Association class III-IV) were included in this prospective study. NT-proBNP and hemodynamic measurements by balloon-tipped pulmonary artery catheter were performed simultaneously. Recompensation strategies included vasodilators, diuretics, and inotropes. The patients were divided in 2 subgroups. Group A, by definition, had a hemodynamic improvement over 24 hours with an increase of cardiac index of >30% and a decrease of pulmonary capillary wedge pressure of >30%. Group B did not show a hemodynamic improvement. Group A had a decline of NT-proBNP levels to 42% of the baseline value over 32 hours. In group B, the NT-pro BNP levels did not change significantly over 32 hours.
The decrease of NT-proBNP correlates with hemodynamic improvement in patients with decompensated heart failure. The relative changes of NT-proBNP seem to be a reliable diagnostic tool in monitoring these patients. There results have been confirmed in a larger patient group.
急性和慢性心力衰竭患者的N末端脑钠肽(NT-proBNP)水平升高。本研究探讨NT-proBNP是否与有创测量的血流动力学参数相关,以及NT-proBNP随时间的下降是否与有创监测的血流动力学改善相关。
本前瞻性研究纳入了20例慢性心力衰竭急性加重(纽约心脏协会III-IV级)的连续患者。同时进行NT-proBNP检测和用带球囊的肺动脉导管进行血流动力学测量。代偿策略包括使用血管扩张剂、利尿剂和正性肌力药物。患者被分为2个亚组。根据定义,A组在24小时内血流动力学有所改善,心脏指数增加>30%,肺毛细血管楔压降低>30%。B组未显示出血流动力学改善。A组在32小时内NT-proBNP水平下降至基线值的42%。在B组中,NT-proBNP水平在32小时内没有显著变化。
NT-proBNP的下降与失代偿性心力衰竭患者的血流动力学改善相关。NT-proBNP的相对变化似乎是监测这些患者的可靠诊断工具。这些结果已在更大的患者群体中得到证实。